Accéder au contenu
Merck
  • Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.

Lancet (London, England) (2013-07-23)
Sophie A Jamal, Ben Vandermeer, Paolo Raggi, David C Mendelssohn, Trish Chatterley, Marlene Dorgan, Charmaine E Lok, David Fitchett, Ross T Tsuyuki
RÉSUMÉ

Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease. We did a systematic review of articles published in any language after Aug 1, 2008, up until Oct 22, 2012, by searching Medline, Embase, International Pharmaceutical Abstracts, Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature. We included all randomised and non-randomised trials that compared outcomes between patients with chronic kidney disease taking calcium-based phosphate binders with those taking non-calcium-based binders. Eligible studies, determined by consensus with predefined criteria, were reviewed, and data were extracted onto a standard form. We combined data from randomised trials to assess the primary outcome of all-cause mortality using the DerSimonian and Laird random effects model. Our search identified 847 reports, of which eight new studies (five randomised trials) met our inclusion criteria and were added to the ten (nine randomised trials) included in our previous meta-analysis. Analysis of the 11 randomised trials (4622 patients) that reported an outcome of mortality showed that patients assigned to non-calcium-based binders had a 22% reduction in all-cause mortality compared with those assigned to calcium-based phosphate binders (risk ratio 0·78, 95% CI 0·61-0·98). Non-calcium-based phosphate binders are associated with a decreased risk of all-cause mortality compared with calcium-based phosphate binders in patients with chronic kidney disease. Further studies are needed to identify causes of mortality and to assess whether mortality differs by type of non-calcium-based phosphate binder. None.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Carbonate de calcium, ACS reagent, ≥99.0%, powder
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E170, precipitated, 98.5-100.5% (based on anhydrous substance)
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, powder, ≤50 μm particle size, 98%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, ReagentPlus®
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, 99.999% trace metals basis
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, BioReagent, suitable for insect cell culture, ≥99.0%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, ≥99.995% trace metals basis
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, BioUltra, precipitated, ≥99.0% (KT)
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, ACS reagent, chelometric standard, 99.95-100.05% dry basis
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, BioXtra, ≥99.0%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Calcium Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Carbonate de calcium, reference material for titrimetry, certified by BAM, ≥99.5%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Carbonate de calcium, tested according to Ph. Eur.
Référence
Conditionnement
Disponibilité
Prix
Quantité